15 / 27
A p r i l 2 2 - 2 3 , 2 0 1 9
A t h e n s , G r e e c e
Page 67
Archives of Clinical Microbiology
ISSN: 1989-8436
Virology and Infectious Diseases 2019
EuroSciCon Conference on
Virology and Infectious Diseases
F
or over two decades now, plants have been explored for their potential to act as production platforms for
biopharmaceuticals such as vaccines and monoclonal antibodies. Without a doubt, the development of plant
viruses as expression vectors for pharmaceutical production have played an integral role in the emergence of plants
as inexpensive and facile systems for the generation of therapeutic proteins. More recently, plant viruses have been
designed as non-toxic nanoparticles which can target a variety of cancers and thus empower the immune system to slow
or even reverse tumour progression. The following presentation describes the employment of plant virus expression
vectors for the treatment of some of the most challenging diseases known today. The presentation concludes with a
projection of the multiple avenues by which virus nanoparticles could impact developing countries.
klh22@cornell.eduPlant virus nanoparticles: New applications for
developing countries
Kathleen Hefferon
Cornell University, USA
Arch Clin Microbiol 2019, Volume:10
DOI: 10.4172/1989-8436-C1-018